Global EditionASIA 中文双语Français
China
Home / China / Health

China boosts medical insurance spending on innovative drugs

Xinhua | Updated: 2025-07-24 13:18
Share
Share - WeChat

BEIJING -- During the 14th Five-Year Plan period (2021-2025), China's medical insurance spending on drugs newly included in the negotiations list, or the innovative drugs, grew significantly, increasing by 40 percent annually, an official from the National Healthcare Security Administration said on Thursday.

In 2024, related spending reached 3.9 times the amount recorded in 2020, Zhang Ke, head of the administration, told a press conference.

During this period, medical insurance fund expenditures totaled 12.13 trillion yuan (about $1.7 trillion), growing at an average annual rate of 9.1 percent, Zhang said.

Top
BACK TO THE TOP
English
Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263

Registration Number: 130349
FOLLOW US